동물용 의약품 시장 규모, 점유율, 성장 및 세계 업계 분석, 지역별 인사이트 및 예측(2026-2034년)

Growth Factors of animal health Market

The global animal health market size was valued at USD 70.16 billion in 2025 and is projected to grow from USD 78.27 billion in 2026 to USD 187.79 billion by 2034, registering a CAGR of 11.56% during 2026-2034. North America dominated the global market with a 34.02% market share in 2025. The market includes pharmaceuticals, vaccines, diagnostics, medicated animal feeds, and nutritional products used to prevent, diagnose, and treat diseases in livestock and companion animals.

The increasing importance of veterinary healthcare in food security, zoonotic disease prevention, livestock productivity, and companion animal wellness is supporting market growth. North America generated USD 14.12 billion in revenue in 2025, maintaining its leading position.

Market Trends

The animal health market trends are increasingly centered on preventive healthcare, advanced diagnostics, digital monitoring, and companion animal wellness. Growing pet adoption and the shift from pet ownership toward pet parenthood are encouraging spending on preventive care, chronic disease management, diagnostics, and premium therapeutics.

Digitalization is also transforming veterinary healthcare through remote monitoring, practice-management software, data analytics, and connected health devices. Public-private partnerships are improving veterinary service availability and supporting disease prevention programs. Sustainability is encouraging manufacturers to develop biologics, immunomodulators, functional feed additives, and alternatives to traditional antimicrobials.

Market Drivers

Rising Incidence of Zoonotic Diseases:

Increasing awareness of animal-borne diseases is encouraging governments, farmers, veterinarians, and pet owners to adopt preventive healthcare solutions. Stronger disease surveillance and food-safety requirements are supporting demand for vaccines, diagnostics, and therapeutics.

Growing Demand for Animal-Derived Protein:

Rising global protein consumption is encouraging livestock producers to improve animal productivity and reduce disease-related losses. Preventive vaccination, parasite control, herd diagnostics, and nutritional solutions are becoming important components of modern livestock management.

Increasing R&D Activities:

Continuous research in veterinary medicine is supporting the development of advanced drugs, vaccines, diagnostics, and nutritional products. Innovations in biologics, molecular diagnostics, and precision healthcare are creating additional market opportunities.

Market Restraints and Challenges

Stringent Regulatory Requirements:

The lengthy and expensive approval process for animal drugs and vaccines remains a major market restraint. Development of new veterinary products can require substantial investment and several years of research and regulatory validation.

Additional challenges include antimicrobial-use restrictions, high product-development costs, uneven veterinary infrastructure, limited access to trained professionals in emerging markets, livestock producer cost sensitivity, and limited awareness of preventive healthcare in certain regions.

Segmentation Analysis

By Product: The market is segmented into drugs, vaccines, feed, and diagnostics. Drugs represented the largest segment with a 45.5% share in 2025, supported by demand for treatments against infectious diseases, parasites, and chronic conditions. Vaccines and diagnostics are gaining importance as preventive and precision healthcare adoption increases.

By Animal: The market includes livestock animals and companion animals. Companion animals held the largest share in 2025, supported by increasing pet adoption, pet humanization, and growing spending on advanced veterinary care. Livestock remains important because of disease-control and food-production requirements.

By End User: Key end users include veterinary hospitals and clinics, animal care and rehabilitation centers, diagnostic centers, and others. Veterinary hospitals and clinics maintain a leading position, while diagnostic centers are expanding with increased adoption of molecular testing and preventive healthcare.

Regional Analysis

North America led the global market with a 34.02% share in 2025, supported by advanced veterinary infrastructure, strong R&D, high companion animal spending, and large-scale livestock operations.

Europe held the second-largest position, supported by stringent animal health regulations, preventive healthcare adoption, and food-safety requirements.

Asia Pacific is expected to witness healthy growth due to expanding livestock populations, rising protein consumption, increasing pet ownership, and improving veterinary infrastructure. Japan benefits from advanced veterinary care and increasing demand for chronic disease management, while China is experiencing increasing demand linked to livestock modernization and urban companion animal healthcare.

Latin America and the Middle East & Africa are also expected to provide opportunities as veterinary infrastructure, disease-control programs, and technology adoption improve.

Key Industry Players

Major companies operating in the animal health market include Zoetis, Intervet International B.V., Elanco, Ceva, Virbac, Merck & Co., Inc., Novartis AG, Emergent BioSolutions, CSL Limited, IDEXX Laboratories, Bayer AG, and Boehringer Ingelheim International GmbH.

Recent Industry Developments

Recent industry developments include expansion of companion animal biologics, strategic acquisitions in veterinary diagnostics, advanced livestock vaccines, digital herd-health monitoring solutions, and innovative parasiticide formulations. These developments demonstrate the industry's increasing focus on preventive care, diagnostics, digitalization, and specialized therapies.

Future Outlook

The animal health market outlook remains positive through 2034. The market is projected to increase from USD 70.16 billion in 2025 to USD 78.27 billion in 2026 and USD 187.79 billion by 2034. IoT-enabled monitoring, connected veterinary devices, precision diagnostics, advanced biologics, preventive vaccination, and public-private partnerships are expected to reshape the industry.

Conclusion

The global animal health market is experiencing strong expansion as livestock producers and companion animal owners increasingly prioritize disease prevention, early diagnosis, and advanced treatment. Rising zoonotic disease concerns, protein consumption, pet humanization, technological innovation, and veterinary R&D are creating sustained market opportunities. Although regulatory requirements, development costs, antimicrobial restrictions, and infrastructure gaps remain challenges, continued innovation and improved healthcare accessibility are expected to support substantial market growth through 2034.

Unit Value (USD Billion)

Segmentation By Product

• Drugs
  • Anti-Infectives
  • Anti-Inflammatory
  • Parasiticides
  • Others
• Vaccines
• Feed
• Diagnostics
  • Instruments
  • Reagents & Consumables

By Animal

• Livestock Animals
• Companion Animals

By End-user

• Veterinary Hospitals & Clinics
• Animal Care & Rehabilitation Centers
• Diagnostic Centers
• Others

By Geography

• North America (the U.S. and Canada)
• Europe (UK, Germany, France, Scandinavia, and the Rest of Europe)
• Asia Pacific (Japan, China, India, Southeast Asia, and the Rest of Asia Pacific)
• Middle East & Africa (South Africa, GCC, and the Rest of the Middle East & Africa)
• Latin America (Brazil, Mexico, and the Rest of Latin America)

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities

4. Key Insights

• 4.1. Recent Industry Developments Such as Mergers & Acquisitions
• 4.2. Prevalence of Key Veterinary Diseases, in Major Countries
• 4.3. Pet Ownership Statistics, in Key Countries
• 4.4. Overview of Pet Insurance, in Key Countries
• 4.5. Technological Advancements in Veterinary Care products
• 4.6. Key Industry Trends

5. Global Animal Health Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Key Findings / Summary
• 5.2. Market Analysis, Insights and Forecast - By Product
  • 5.2.1. Drugs
    • 5.2.1.1. Anti-Infectives
    • 5.2.1.2. Anti-Inflammatory
    • 5.2.1.3. Parasiticides
    • 5.2.1.4. Others
  • 5.2.2. Vaccines
  • 5.2.3. Feed
  • 5.2.4. Diagnostics
    • 5.2.4.1. Instruments
    • 5.2.4.2. Reagents & Consumables
• 5.3. Market Analysis, Insights and Forecast - By Animal
  • 5.3.1. Livestock Animals
  • 5.3.2. Companion Animals
• 5.4. Market Analysis, Insights and Forecast - By End User
  • 5.4.1. Veterinary Hospitals & Clinics
  • 5.4.2. Animal Care & Rehabilitation Centers
  • 5.4.3. Diagnostic Centers
  • 5.4.4. Others
• 5.5. Market Analysis, Insights and Forecast - By Region
  • 5.5.1. North America
  • 5.5.2. Europe
  • 5.5.3. Asia Pacific
  • 5.5.4. Latin America
  • 5.5.5. Middle East & Africa

6. North America Animal Health Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Key Findings / Summary
• 6.2. Market Analysis - By Product
  • 6.2.1. Drugs
    • 6.2.1.1. Anti-Infectives
    • 6.2.1.2. Anti-Inflammatory
    • 6.2.1.3. Parasiticides
    • 6.2.1.4. Others
  • 6.2.2. Vaccines
  • 6.2.3. Feed
  • 6.2.4. Diagnostics
    • 6.2.4.1. Instruments
    • 6.2.4.2. Reagents & Consumables
• 6.3. Market Analysis - By Animal
  • 6.3.1. Livestock Animals
  • 6.3.2. Companion Animals
• 6.4. Market Analysis - By End User
  • 6.4.1. Veterinary Hospitals & Clinics
  • 6.4.2. Animal Care & Rehabilitation Centers
  • 6.4.3. Diagnostic Centers
  • 6.4.4. Others
• 6.5. Market Analysis - By Country
  • 6.5.1. U.S.
  • 6.5.2. Canada

7. Europe Animal Health Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Key Findings / Summary
• 7.2. Market Analysis - By Product
  • 7.2.1. Drugs
    • 7.2.1.1. Anti-Infectives
    • 7.2.1.2. Anti-Inflammatory
    • 7.2.1.3. Parasiticides
    • 7.2.1.4. Others
  • 7.2.2. Vaccines
  • 7.2.3. Feed
  • 7.2.4. Diagnostics
    • 7.2.4.1. Instruments
    • 7.2.4.2. Reagents & Consumables
• 7.3. Market Analysis - By Animal
  • 7.3.1. Livestock Animals
  • 7.3.2. Companion Animals
• 7.4. Market Analysis - By End User
  • 7.4.1. Veterinary Hospitals & Clinics
  • 7.4.2. Animal Care & Rehabilitation Centers
  • 7.4.3. Diagnostic Centers
  • 7.4.4. Others
• 7.5. Market Analysis - By Country/Sub-region
  • 7.5.1. U.K.
  • 7.5.2. Germany
  • 7.5.3. France
  • 7.5.4. Spain
  • 7.5.5. Italy
  • 7.5.6. Scandinavia
  • 7.5.7. Rest of Europe

8. Asia Pacific Animal Health Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Key Findings / Summary
• 8.2. Market Analysis - By Product
  • 8.2.1. Drugs
    • 8.2.1.1. Anti-Infectives
    • 8.2.1.2. Anti-Inflammatory
    • 8.2.1.3. Parasiticides
    • 8.2.1.4. Others
  • 8.2.2. Vaccines
  • 8.2.3. Feed
  • 8.2.4. Diagnostics
    • 8.2.4.1. Instruments
    • 8.2.4.2. Reagents & Consumables
• 8.3. Market Analysis - By Animal
  • 8.3.1. Livestock Animals
  • 8.3.2. Companion Animals
• 8.4. Market Analysis - By End User
  • 8.4.1. Veterinary Hospitals & Clinics
  • 8.4.2. Animal Care & Rehabilitation Centers
  • 8.4.3. Diagnostic Centers
  • 8.4.4. Others
• 8.5. Market Analysis - By Country/Sub-region
  • 8.5.1. Japan
  • 8.5.2. China
  • 8.5.3. India
  • 8.5.4. Australia
  • 8.5.5. Southeast Asia
  • 8.5.6. Rest of Asia Pacific

9. Latin America Animal Health Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Key Findings / Summary
• 9.2. Market Analysis - By Product
  • 9.2.1. Drugs
    • 9.2.1.1. Anti-Infectives
    • 9.2.1.2. Anti-Inflammatory
    • 9.2.1.3. Parasiticides
    • 9.2.1.4. Others
  • 9.2.2. Vaccines
  • 9.2.3. Feed
  • 9.2.4. Diagnostics
    • 9.2.4.1. Instruments
    • 9.2.4.2. Reagents & Consumables
• 9.3. Market Analysis - By Animal
  • 9.3.1. Livestock Animals
  • 9.3.2. Companion Animals
• 9.4. Market Analysis - By End User
  • 9.4.1. Veterinary Hospitals & Clinics
  • 9.4.2. Animal Care & Rehabilitation Centers
  • 9.4.3. Diagnostic Centers
  • 9.4.4. Others
• 9.5. Market Analysis - By Country/Sub-region
  • 9.5.1. Brazil
  • 9.5.2. Mexico
  • 9.5.3. Rest of Latin America

10. Middle East & Africa Animal Health Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Key Findings / Summary
• 10.2. Market Analysis - By Product
  • 10.2.1. Drugs
    • 10.2.1.1. Anti-Infectives
    • 10.2.1.2. Anti-Inflammatory
    • 10.2.1.3. Parasiticides
    • 10.2.1.4. Others
  • 10.2.2. Vaccines
  • 10.2.3. Feed
  • 10.2.4. Diagnostics
    • 10.2.4.1. Instruments
    • 10.2.4.2. Reagents & Consumables
• 10.3. Market Analysis - By Animal
  • 10.3.1. Livestock Animals
  • 10.3.2. Companion Animals
• 10.4. Market Analysis - By End User
  • 10.4.1. Veterinary Hospitals & Clinics
  • 10.4.2. Animal Care & Rehabilitation Centers
  • 10.4.3. Diagnostic Centers
  • 10.4.4. Others
• 10.5. Market Analysis - By Country/Sub-region
  • 10.5.1. GCC Countries
  • 10.5.2. South Africa
  • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

• 11.1. Key Industry Developments
• 11.2. Global Market Share Analysis (2025)
• 11.3. Competition Dashboard
• 11.4. Comparative Analysis - Major Players
• 11.5. Company Profiles
  • 11.5.1. Zoetis
    • 11.5.1.1. Overview,
    • 11.5.1.2. Products & services,
    • 11.5.1.3. SWOT analysis,
    • 11.5.1.4. Recent developments,
    • 11.5.1.5. strategies,
    • 11.5.1.6. financials (based on availability)
  • 11.5.2. Intervet Inc.
    • 11.5.2.1. Overview,
    • 11.5.2.2. Products & services,
    • 11.5.2.3. SWOT analysis,
    • 11.5.2.4. Recent developments,
    • 11.5.2.5. strategies,
    • 11.5.2.6. financials (based on availability)
  • 11.5.3. Elanco
    • 11.5.3.1. Overview,
    • 11.5.3.2. Products & services,
    • 11.5.3.3. SWOT analysis,
    • 11.5.3.4. Recent developments,
    • 11.5.3.5. strategies,
    • 11.5.3.6. financials (based on availability)
  • 11.5.4. Ceva
    • 11.5.4.1. Overview,
    • 11.5.4.2. Products & services,
    • 11.5.4.3. SWOT analysis,
    • 11.5.4.4. Recent developments,
    • 11.5.4.5. strategies,
    • 11.5.4.6. financials (based on availability)
  • 11.5.5. Virbac
    • 11.5.5.1. Overview,
    • 11.5.5.2. Products & services,
    • 11.5.5.3. SWOT analysis,
    • 11.5.5.4. Recent developments,
    • 11.5.5.5. strategies,
    • 11.5.5.6. financials (based on availability)
  • 11.5.6. Merck & Co., Inc.
    • 11.5.6.1. Overview,
    • 11.5.6.2. Products & services,
    • 11.5.6.3. SWOT analysis,
    • 11.5.6.4. Recent developments,
    • 11.5.6.5. strategies,
    • 11.5.6.6. financials (based on availability)
  • 11.5.7. Novartis AG
    • 11.5.7.1. Overview,
    • 11.5.7.2. Products & services,
    • 11.5.7.3. SWOT analysis,
    • 11.5.7.4. Recent developments,
    • 11.5.7.5. strategies,
    • 11.5.7.6. financials (based on availability)
  • 11.5.8. Emergent BioSolutions, Inc.
    • 11.5.8.1. Overview,
    • 11.5.8.2. Products & services,
    • 11.5.8.3. SWOT analysis,
    • 11.5.8.4. Recent developments,
    • 11.5.8.5. strategies,
    • 11.5.8.6. financials (based on availability)
  • 11.5.9. Bayer AG
    • 11.5.9.1. Overview,
    • 11.5.9.2. Products & services,
    • 11.5.9.3. SWOT analysis,
    • 11.5.9.4. Recent developments,
    • 11.5.9.5. strategies,
    • 11.5.9.6. financials (based on availability)
  • 11.5.10. Boehringer Ingelheim International GmbH
    • 11.5.10.1. Overview,
    • 11.5.10.2. Products & services,
    • 11.5.10.3. SWOT analysis,
    • 11.5.10.4. Recent developments,
    • 11.5.10.5. strategies,
    • 11.5.10.6. financials (based on availability)
  • 11.5.11. Other Prominent Players
    • 11.5.11.1. Overview,
    • 11.5.11.2. Products & services,
    • 11.5.11.3. SWOT analysis,
    • 11.5.11.4. Recent developments,
    • 11.5.11.5. strategies,
    • 11.5.11.6. financials (based on availability)

12. Strategic Recommendations